Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1951 1
1953 2
1955 1
1959 1
1961 1
1963 1
1964 1
1965 2
1966 1
1967 1
1969 5
1971 2
1972 3
1973 2
1974 3
1975 1
1976 2
1979 1
1996 1
2002 4
2003 1
2004 4
2005 5
2006 10
2007 4
2008 9
2009 7
2010 9
2011 5
2012 4
2013 3
2014 2
2015 2
2018 1
2019 3
2020 3
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Results by year
Filters applied: . Clear all
Page 1
MSH6 syndrome.
Suchy J, Lubinski J. Suchy J, et al. Hered Cancer Clin Pract. 2008 Jun 15;6(2):103-4. doi: 10.1186/1897-4287-6-2-103. Hered Cancer Clin Pract. 2008. PMID: 19804606 Free PMC article. No abstract available.
Molecular basis of inherited predispositions for tumors.
Lubiński J, Górski B, Kurzawski G, Jakubowska A, Cybulski C, Suchy J, Debniak T, Grabowska E, Lener M, Nej K. Lubiński J, et al. Among authors: suchy j. Acta Biochim Pol. 2002;49(3):571-81. Acta Biochim Pol. 2002. PMID: 12422228 Free article. Review.
Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models.
Kamoun WS, Dugast AS, Suchy JJ, Grabow S, Fulton RB, Sampson JF, Luus L, Santiago M, Koshkaryev A, Sun G, Askoxylakis V, Tam E, Huang ZR, Drummond DC, Sawyer AJ. Kamoun WS, et al. Among authors: suchy jj. Mol Cancer Ther. 2020 Jan;19(1):270-281. doi: 10.1158/1535-7163.MCT-19-0414. Epub 2019 Oct 9. Mol Cancer Ther. 2020. PMID: 31597714
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models.
Kamoun WS, Kirpotin DB, Huang ZR, Tipparaju SK, Noble CO, Hayes ME, Luus L, Koshkaryev A, Kim J, Olivier K, Kornaga T, Oyama S, Askoxylakis V, Pien C, Kuesters G, Dumont N, Lugovskoy AA, Schihl SA, Wilton JH, Geddie ML, Suchy J, Grabow S, Kohli N, Reynolds CP, Blaydes R, Zhou Y, Sawyer AJ, Marks JD, Drummond DC. Kamoun WS, et al. Among authors: suchy j. Nat Biomed Eng. 2019 Apr;3(4):264-280. doi: 10.1038/s41551-019-0385-4. Epub 2019 Apr 5. Nat Biomed Eng. 2019. PMID: 30952988
Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity.
Tam EM, Fulton RB, Sampson JF, Muda M, Camblin A, Richards J, Koshkaryev A, Tang J, Kurella V, Jiao Y, Xu L, Zhang K, Kohli N, Luus L, Hutto E, Kumar S, Lulo J, Paragas V, Wong C, Suchy J, Grabow S, Dugast AS, Zhang H, Depis F, Feau S, Jakubowski A, Qiao W, Craig G, Razlog M, Qiu J, Zhou Y, Marks JD, Croft M, Drummond DC, Raue A. Tam EM, et al. Among authors: suchy j. Sci Transl Med. 2019 Oct 2;11(512):eaax0720. doi: 10.1126/scitranslmed.aax0720. Sci Transl Med. 2019. PMID: 31578241
CHEK2 mutations and HNPCC-related colorectal cancer.
Suchy J, Cybulski C, Wokołorczyk D, Oszurek O, Górski B, Debniak T, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dziuba I, Gogacz M, Wiśniowski R, Wandzel P, Banaszkiewicz Z, Kurzawski G, Kładny J, Narod SA, Lubiński J. Suchy J, et al. Int J Cancer. 2010 Jun 15;126(12):3005-9. doi: 10.1002/ijc.25003. Int J Cancer. 2010. PMID: 19876921 Free article.
100 results